Active, not recruitingNCT07116551

Early Feasibility Study (EFS) of Abbott's Balloon-expandable (BE) TAVI System for the Treatment of Severe, Symptomatic Aortic Stenosis

Abbott Medical DevicesMultiple US sitesView on ClinicalTrials.gov

AI Description

The purpose of this study is to evaluate the safety and functionality of Abbott's BE TAVI system for the treatment of patients with symptomatic severe aortic valve stenosis.

Report inaccurate information

Who can join
adult, older adult
Participants
11
Expected completion
2031-06
Funded by
industry

Conditions studied

Symptomatic Severe Aortic Stenosis

What is being tested

  • DEVICE: Abbott BE TAVI System

What it measures

  • Device success, Intended performance of the valve, 30 days
  • Technical success, Successful access, delivery of the Abbott BE TAVI valve, and retrieval of the delivery system., From start of procedure up to end of procedure

Centers Participating

These centers are participating in this study. Reach out to them directly to learn more.

Data Sources and Methodology

Registry entry updated 2026-02-06

Deciding whether to join a study is your choice, and you can ask a study team questions before you decide anything.

If you would rather we did it with you, call us on (656) 206-4686.